American Society of Clinical Oncology

SHERPA: White

People

  1. Norton
    Norton
  2. Hudis
    Hudis
  3. Rudin
    Rudin
  4. Cheung
    Cheung
  5. Chandarlapaty
    Chandarlapaty
  6. Kris
    Kris
  7. Panageas
    Panageas
  8. Kushner
    Kushner
  9. Ladanyi
    Ladanyi
  10. Seidman
    Seidman

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (564)
  2. Department of Medicine (466)
  3. Solid Tumor Oncology Division (437)
  4. GSK Faculty (378)
  5. Breast Medicine Service (213)
  6. Survivorship Research (202)
  7. Epidemiology and Biostatistics (201)
  8. Biostatistics Service (184)
  9. Human Oncology and Pathogenesis Program (158)
  10. Population Sciences Research Program (145)
Search Within
  1. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
Formats
  1. Meeting Abstract (335)
  2. Journal Article (219)
  3. Editorial (4)
  4. Guidelines (3)
  5. Correspondence (2)
  6. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (564)
  2. Department of Medicine (466)
  3. Solid Tumor Oncology Division (437)
  4. GSK Faculty (378)
  5. Breast Medicine Service (213)
  6. Survivorship Research (202)

More Groups

People
  1. Larry Norton (158)
  2. Clifford Hudis (98)
  3. Paul Chapman (94)
  4. Charles Rudin (92)
  5. Nai-Kong Cheung (72)
  6. Jedd Wolchok (52)

More People

Years
  1. 2025 (3)
  2. 2024 (31)
  3. 2023 (26)
  4. 2022 (28)
  5. 2021 (16)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (538)
  2. JCO Precision Oncology (21)
  3. American Society of Clinical Oncology Educational Book (4)
  4. Journal of Oncology Practice (1)

Results (564)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of a novel capecitabine schedule based on Norton-Simon mathematical modeling
    Meeting Abstract

    Theodoulou, M.; Traina, T. A.; Dugan, U.; Lake, D.; Fornier, M.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase II trial of extended-dosing temozolomide in patients with melanoma
    Meeting Abstract

    Rietschel, P.; Ejadi, S.; Wolchok, J.; Krown, S.; Gerst, S.; Jungbluth, A.; Busam, K.; Panageas, K.; Smith, K.; Chapman, P.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of the combination of anti-GD2 antibody 3F8 and barley-derived (1→3,1→4)-ß-D-glucan for patients with resistant neuroblastoma
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Specific gene expression profiles and unique chromosomal abnormalities are associated with regressing tumors among infants with disseminated neuroblastoma
    Meeting Abstract

    Lavarino, C.; Cheung, N.; de Torres, C.; Domenech, G.; Garcia, I.; Alaminos, M.; Ríos, J.; Gerald, W.; Kushner, B.; LaQuaglia, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Long-term complications of neuroblastoma: A report from the Childhood Cancer Survivor Study
    Meeting Abstract

    Laverdiere, C.; Liu, Q.; Yasui, Y.; Nathan, P. C.; Gurney, J.; Stovall, M.; Diller, L.; Cheung, N. K.; Wolden, S.; Robison, L. L.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Anti-GD2 monoclonal antibody 3F8 plus granulocyte-macrophage colony-stimulating factor (GM-CSF) for primary refractory neuroblastoma (NB) in bone marrow (BM)
    Meeting Abstract

    Kushner, B. H.; Kramer, K.; Modak, S.; Cheung, N. V.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Metastatic neuroblastoma (NB) to the central nervous system (CNS): Improved outcome with combined modality including 131-I-8H9 or 131-I-3F8 radioimmunotherapy (RIT) delivered through the cerebrospinal fluid (CSF)
    Meeting Abstract

    Kramer, K.; Modak, S.; Kushner, B. H.; Souweidane, M.; Wolden, S.; Humm, J.; Zanzonico, P.; Smith-Jones, P.; Larson, S.; Cheung, N.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Visits to urologists and radiation oncologists prior to treatment decision making for clinically localized prostate cancer (LCaP)
    Meeting Abstract

    Jang, T. L.; Bekelman, J. E.; Liu, Y.; Bach, P. B.; Basch, E. M.; Elkin, E. B.; Zelefsky, M. J.; Scardino, P. T.; Begg, C. B.; Schrag, D.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Construction and targeting of a 5F11-scFv-methioninase fusion protein for antibody-directed enzyme pro-drug therapy (ADEPT) against neuroblastoma
    Meeting Abstract

    Hu, J.; Guo, H.; Xu, H.; Cheung, N. V.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Adjuvant (adj) bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-p) in early stage breast cancer (BC) patients (pts): Cardiac safety
    Meeting Abstract

    Dickler, M. N.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Sugarman, S.; Norton, L.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save